Journal
NANOMEDICINE
Volume 13, Issue 18, Pages -Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2018-0163
Keywords
blood-brain barrier; nanotechnology; neurodegenerative disease; neuroinflammation; theranostics
Funding
- Joint Program of Yunnan Province and Kunming Medical University [2017FE468-249]
- Fund of Yunnan Key Laboratory of Stem Cell and Regenerative Medicine
Ask authors/readers for more resources
Alzheimer's disease, Parkinson's disease and stroke are the most common CNS diseases, all characterized by progressive cellular dysfunction and death in specific areas of the nervous system. Therapeutic development for these diseases has lagged behind other disease areas due to difficulties in early diagnosis, long disease courses and drug delivery challenges, not least due to the blood-brain barrier. Over recent decades, nanotechnology has been explored as a potential tool for the diagnosis, treatment and monitoring of CNS diseases. In this review, we describe the application of nanotechnology to common CNS diseases, highlighting disease pathogenesis and the underlying mechanisms and promising functional outcomes that make nanomaterials ideal candidates for early diagnosis and therapy. Moreover, we discuss the limitations of nanotechnology, and possible solutions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available